These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Dramatic differences in the binding of UDP-galactose and UDP-glucose to UDP-galactose 4-epimerase from Escherichia coli. Thoden JB; Holden HM Biochemistry; 1998 Aug; 37(33):11469-77. PubMed ID: 9708982 [TBL] [Abstract][Full Text] [Related]
48. Tautomerization in the UDP-galactopyranose mutase mechanism: a DFT-cluster and QM/MM investigation. Huang W; Gauld JW J Phys Chem B; 2012 Dec; 116(48):14040-50. PubMed ID: 23148701 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and analysis of substrate analogues for UDP-galactopyranose mutase: implication for an oxocarbenium ion intermediate in the catalytic mechanism. Itoh K; Huang Z; Liu HW Org Lett; 2007 Mar; 9(5):879-82. PubMed ID: 17266324 [TBL] [Abstract][Full Text] [Related]
50. Blood group B galactosyltransferase: insights into substrate binding from NMR experiments. Angulo J; Langpap B; Blume A; Biet T; Meyer B; Krishna NR; Peters H; Palcic MM; Peters T J Am Chem Soc; 2006 Oct; 128(41):13529-38. PubMed ID: 17031966 [TBL] [Abstract][Full Text] [Related]
51. Direct biochemical evidence for the utilization of UDP-bacillosamine by PglC, an essential glycosyl-1-phosphate transferase in the Campylobacter jejuni N-linked glycosylation pathway. Glover KJ; Weerapana E; Chen MM; Imperiali B Biochemistry; 2006 Apr; 45(16):5343-50. PubMed ID: 16618123 [TBL] [Abstract][Full Text] [Related]
52. Characterization of CJ1293, a new UDP-GlcNAc C6 dehydratase from Campylobacter jejuni. Creuzenet C FEBS Lett; 2004 Feb; 559(1-3):136-40. PubMed ID: 14960321 [TBL] [Abstract][Full Text] [Related]
53. Deciphering the sugar biosynthetic pathway and tailoring steps of nucleoside antibiotic A201A unveils a GDP-l-galactose mutase. Zhu Q; Chen Q; Song Y; Huang H; Li J; Ma J; Li Q; Ju J Proc Natl Acad Sci U S A; 2017 May; 114(19):4948-4953. PubMed ID: 28438999 [TBL] [Abstract][Full Text] [Related]
54. Investigation of the nucleotide triphosphate substrate specificity of Homo sapiens UDP-N-acetylgalactosamine pyrophosphorylase (AGX1). Xue M; Guan W; Zou Y; Fang J; Liu XW; Wang PG; Wang F Bioorg Med Chem Lett; 2012 Jun; 22(12):3957-61. PubMed ID: 22595178 [TBL] [Abstract][Full Text] [Related]
55. Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. McNally DJ; Lamoureux MP; Karlyshev AV; Fiori LM; Li J; Thacker G; Coleman RA; Khieu NH; Wren BW; Brisson JR; Jarrell HC; Szymanski CM J Biol Chem; 2007 Sep; 282(39):28566-28576. PubMed ID: 17675288 [TBL] [Abstract][Full Text] [Related]
56. Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design. Boechi L; de Oliveira CA; Da Fonseca I; Kizjakina K; Sobrado P; Tanner JJ; McCammon JA Protein Sci; 2013 Nov; 22(11):1490-501. PubMed ID: 23934860 [TBL] [Abstract][Full Text] [Related]
57. Substrate-induced conformational changes and dynamics of UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase-2. Milac AL; Buchete NV; Fritz TA; Hummer G; Tabak LA J Mol Biol; 2007 Oct; 373(2):439-51. PubMed ID: 17850816 [TBL] [Abstract][Full Text] [Related]
58. Reversible and efficient inhibition of UDP-galactopyranose mutase by electrophilic, constrained and unsaturated UDP-galactitol analogues. Ansiaux C; N'Go I; Vincent SP Chemistry; 2012 Nov; 18(46):14860-6. PubMed ID: 23015271 [TBL] [Abstract][Full Text] [Related]